NCT00001761View on ClinicalTrials.gov

Phase I Trial of Recombinant Human Interleukin-10 (SCH 52000) in Patients With Wegener's Granulomatosis

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

February 28, 1998

Study Completion Date

April 30, 2000

Conditions

VasculitisWegener's Granulomatosis

Interventions

DRUG

Interleukin-10

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH